Lifecore Biomedical (Lifecore Biomedical) Gross Profit : $27.8 Mil (TTM As of May. 2023)

Lifecore Biomedical Gross Profit Chart

Lifecore Biomedical Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
Gross Profit		Get a 7-Day Free Trial					81.00	39.39	38.94	39.07	27.99

Lifecore Biomedical Quarterly Data
	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23
Gross Profit	Get a 7-Day Free Trial															7.43	6.25	7.11	5.98	8.42

Competitive Comparison of Lifecore Biomedical's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifecore Biomedical's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Gross Profit distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Gross Profit falls into.

Lifecore Biomedical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Lifecore Biomedical's Gross Profit for the fiscal year that ended in May. 2023 is calculated as

Lifecore Biomedical's Gross Profit for the quarter that ended in May. 2023 is calculated as

Gross Profit for the trailing twelve months (TTM) ended in May. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.8 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Lifecore Biomedical's Gross Margin % for the quarter that ended in May. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Lifecore Biomedical  (NAS:LFCR) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lifecore Biomedical had a gross margin of 32.97% for the quarter that ended in May. 2023 => Competition eroding margins

Lifecore Biomedical Gross Profit Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifecore Biomedical (Lifecore Biomedical) Business Description